[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Anesthesia Drug Market Analysed by Kalorama Information

12 Apr 2012 • by Natalie Aster

There are several issues and trends that are impacting the anesthesia drug market. Many of the issues are centered on safety issues, which are probably one of the most important aspects of the administration of anesthetic agents. This industry is a mature industry so it does not have the typical competitive issues often seen in other pharmaceutical segments. However, there are some issues that concern research and development of promising areas in anesthesia.

The newly published Kalorama Information report «The World Anesthesia Drug Market (General, Local, Adjunctive)» focuses on three primary segments of anesthesia:

  • General Anesthesia 
  • Local Anesthesia 
  • Adjunctive Therapies in Anesthesia

Revenues for each segment were generated using dollar and unit sales for each product. Forecasted figures were generated using a combination of projected surgical procedures, patent and exclusivity expirations, pricing trends, new developments and other factors.

Report Details:

The World Anesthesia Drug Market (General, Local, Adjunctive)
Published: March, 2012
Pages: 190
Price: US$ 3.995,00

The report includes statistical information for surgical procedures, incidence of conditions requiring surgery, and other relevant information. Statistical information is presented as a worldwide overview, with special emphasis on the U.S. Product chapters in this report provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.

More information can be found in the report “The World Anesthesia Drug Market (General, Local, Adjunctive)” by Kalorama Information.

To order the report or ask for sample pages contact [email protected]


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest